Global Tuberculosis Testing Market
The Global Tuberculosis Testing Market is projected to grow from USD 2.05 billion in 2021 to USD 2.60 billion by 2027 at a CAGR of over 3.8% during the forecast period.
Tuberculosis is a communicable disease cause by a type of bacteria named as “Mycobacterium Tuberculosis.” The infectious bacteria generally attack to the patient`s Lungs. The infection can also cause to the other parts of body such as Brain and Spine. There are couple of tests to detect the Tuberculosis Bacteria in the body are The Blood Test and the skin Test (TST).
Market Drivers
The growing incidence of the disorder will ultimately boost demand for these diagnostics. Increasing screening rate in high burden regions, affordability of diagnostics, advanced methodologies faster clinical decision and reduction in mortality rate are the key segments of development. Enhanced preventive & curative diagnosis rate are the main moto of these initiatives. This ultimately results in increasing demand for diagnostic test and TB Diagnostic Market. Spreading awareness about importance of diagnosis & treatment are the important factor in growing the screening and diagnosis rate which indirectly helping in drive the TB Diagnostic Market.
Market Restraints
Drug resistance in Tuberculosis patients undergoing treatment is the one of the key factors for healthcare professionals because of improper treatment as wrong drug regime & incorrect dosage form led to restraining the market growth. High price diagnostic technology is one of the strong hindrances for market growth in the emerging regions.
Market Segmentation
The Global Tuberculosis Testing Market is segmented into Test Type, End User and Region. By Test Type such as Chest X-Ray, Culture-Based Test, Interferon Gamma Release Assay (IGRA), Mantoux Test (TST), Nucleic Acid Testing (NAT), Xpert Test, Serological Test, Smear Microscopy, Other Tests (ADA,etc.) By End User such as Academics & Research, Hospitals Laboratories, Physicians Office Laboratories, Reference Laboratories, Others (Home Health Agencies,etc).
Regional Analysis
Global Tuberculosis Testing Market is segmented into five regions such as North America, Europe, Asia Pacific, Latin America, and MEA. Among all of the regions Asia Pacific dominated the Global Tuberculosis Testing Market and is expected to grow at highest CAGR during the forecast period. The Middle East & Africa Region anticipated to have the third-largest share due to relatively faster speed of increasing incidences of Tuberculosis. Europe captured the third highest Tuberculosis Diagnostic Market share in 2020 that is attribute to the strong Diagnostic volume in Major European Countries & increasing expenditure on Research & Development in Europe leading to new product launches.
Key Players
Various Key Players are listed in this report such as Abbott Laboratories, Inc., Akonni Biosystems, Inc. Alere, Inc., Becton, Dickinson and Company, BioMerieux SA, Cepheid, Inc., Creative Diagnostics Danaher Corporation, Epistem Ltd., F. Hoffmann-La Roche AG.
Market Taxonomy
By Test Type
By End User
By Region
Global Tuberculosis Testing Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Tuberculosis Testing Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Tuberculosis Testing Market, By Test Type
5.1 Chest X-Ray
5.2 Culture-Based Test
5.3 Interferon Gamma Release Assay (IGRA)
5.4 Mantoux Test (TST)
5.5 Nucleic Acid Testing (NAT), Xpert Test
5.6 Serological Test, Smear Microscopy
5.7 Other Tests (ADA,etc.)
6.Global Tuberculosis Testing Market, By End User
6.1 Academics & Research
6.2 Hospitals Laboratories
6.3 Physician Office Laboratories
6.4 Reference Laboratories
6.5 Others (Home Health Agencies,etc).
7 Global Tuberculosis Testing Market, By Region
7.1 Global Health and Wellness Market Share Analysis, By Region
7.2 Global Health and Wellness Market Share Analysis, By Region
7.3 Global Health and Wellness Market Size and Forecast, By Region
8 North America Tuberculosis Testing Market Analysis and Forecast (2022 – 2027)
8.1 Introduction
8.2 North America Tuberculosis Testing Market Share Analysis, By Test Type
8.3 North America Tuberculosis Testing Market Share Analysis, By End User
8.4 North America Tuberculosis Testing Market Size and Forecast, By Country
8.4.1. U.S
8.4.2 Canada
8.4.3 Mexico
9 Europe Tuberculosis Testing Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 Europe Tuberculosis Testing Market Share Analysis, By Test Type
9.3 Europe Tuberculosis Testing Market Share Analysis, By End User
9.4 Europe Tuberculosis Testing Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10 Asia Pacific Tuberculosis Testing Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Asia Pacific Tuberculosis Testing Market Share Analysis, By Test Type
10.3 Asia Pacific Tuberculosis Testing Market Share Analysis, By End User
10.4 Asia Pacific Tuberculosis Testing Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11 Latin America Tuberculosis Testing Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Latin America Tuberculosis Testing Market Share Analysis, By Test Type
11.3 Latin America Tuberculosis Testing Market Share Analysis, By End User
11.4 Latin America Tuberculosis Testing Market Size and Forecast, By Country
12 Middle East Tuberculosis Testing Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Middle East Tuberculosis Testing Market Share Analysis, By Test Type
12.3 Middle East Tuberculosis Testing Market Share Analysis, By End User
12.4 Middle East Tuberculosis Testing Market Size and Forecast, By Country
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14 Company Profiles
14.1 Abbott Laboratories, Inc
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 Akonni Biosystems, Inc.
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Alere, Inc.,
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Becton, Dickinson and Company
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 BioMerieux SA
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 Cepheid, Inc.,
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 Creative Diagnostics Danaher Corporation
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 Epistem Ltd.,
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 F. Hoffmann-La Roche AG.
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
